Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Patil

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Head & Neck|March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysisSarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
South Asian Journal of Cancer|August 17, 2018
Patterns of epidermal growth factor receptor testing across 111 tertiary care centers in India: Result of a questionnaire-based surveyKumar Prabhash, Purvish M Parikh, Senthil J Rajappa, et al.
Journal of Medicinal Chemistry|April 10, 2018
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234Krisztina M Papp-Wallace, Nhu Q Nguyen, Michael R Jacobs, et al.
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Head & Neck|March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single instituteSarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.
Eclinicalmedicine|May 31, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung CancerVijay Patil, Vanita Noronha, Amit Joshi, et al.
JAMA Network Open|August 6, 2024
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical TrialVikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, et al.
Cancers|January 28, 2026
Decoding Osteoradionecrosis of the Jaw: Radiological Progression and a Novel CT-Based Grading SystemVasundhara Patil, Pritesh Shah, Abhishek Mahajan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)Vanita Noronha, Vijay Patil, Nandini Menon, et al.
JCO Global Oncology|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Head & Neck|March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysisSarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
South Asian Journal of Cancer|August 17, 2018
Patterns of epidermal growth factor receptor testing across 111 tertiary care centers in India: Result of a questionnaire-based surveyKumar Prabhash, Purvish M Parikh, Senthil J Rajappa, et al.
Journal of Medicinal Chemistry|April 10, 2018
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234Krisztina M Papp-Wallace, Nhu Q Nguyen, Michael R Jacobs, et al.
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Head & Neck|March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single instituteSarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.
Eclinicalmedicine|May 31, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung CancerVijay Patil, Vanita Noronha, Amit Joshi, et al.
JAMA Network Open|August 6, 2024
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical TrialVikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, et al.
Cancers|January 28, 2026
Decoding Osteoradionecrosis of the Jaw: Radiological Progression and a Novel CT-Based Grading SystemVasundhara Patil, Pritesh Shah, Abhishek Mahajan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)Vanita Noronha, Vijay Patil, Nandini Menon, et al.
JCO Global Oncology|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
Pageof 19